XML 97 R80.htm IDEA: XBRL DOCUMENT v3.22.1
Long-Term Investments (Details) - Schedule of balance sheets - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
BioFirst [Member]      
Condensed Balance Sheet Statements, Captions [Line Items]      
Current Assets $ 2,147,097 $ 2,205,669 $ 1,299,822
Noncurrent Assets 812,865 959,454 2,540,041
Current Liabilities 3,237,623 2,909,703 1,986,340
Noncurrent Liabilities 17,741 32,522 73,197
Shareholders’ Deficit (295,402) 222,898 1,780,326
Rgene [Member]      
Condensed Balance Sheet Statements, Captions [Line Items]      
Current Assets 221,169 73,452 123,958
Noncurrent Assets 355,420 374,423 412,342
Current Liabilities 2,164,077 1,934,786 1,392,756
Noncurrent Liabilities 38,953
Shareholders’ Deficit $ (1,587,488) $ (1,486,911) $ (895,409)